Log in

NASDAQ:ATRIAtrion Stock Price, Forecast & News

-1.12 (-0.17 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: $645.91
50-Day Range
MA: $642.85
52-Week Range
Now: $645.91
Volume5,084 shs
Average Volume5,094 shs
Market Capitalization$1.19 billion
P/E Ratio33.21
Dividend Yield0.96%
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Read More
Atrion logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.97 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:ATRI



Sales & Book Value

Annual Sales$155.07 million
Cash Flow$25.63 per share
Book Value$128.24 per share


Net Income$36.76 million


Market Cap$1.19 billion
Next Earnings Date11/6/2020 (Estimated)
OptionableNot Optionable
-1.12 (-0.17 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Atrion (NASDAQ:ATRI) Frequently Asked Questions

How has Atrion's stock been impacted by COVID-19 (Coronavirus)?

Atrion's stock was trading at $667.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ATRI shares have decreased by 3.2% and is now trading at $645.91.
View which stocks have been most impacted by Coronavirus

When is Atrion's next earnings date?

Atrion is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Atrion

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) posted its quarterly earnings data on Friday, November, 1st. The medical instruments supplier reported $5.15 earnings per share (EPS) for the quarter. The medical instruments supplier earned $38.88 million during the quarter. Atrion had a net margin of 23.06% and a return on equity of 15.57%.
View Atrion's earnings history

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion announced a quarterly dividend on Friday, May 22nd. Shareholders of record on Monday, June 15th will be paid a dividend of $1.55 per share on Tuesday, June 30th. This represents a $6.20 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date is Friday, June 12th.
View Atrion's dividend history

Has Atrion been receiving favorable news coverage?

News headlines about ATRI stock have been trending very positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Atrion earned a coverage optimism score of 4.0 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Atrion

Who are some of Atrion's key competitors?

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), AbbVie (ABBV), ABM Industries (ABM), Caterpillar (CAT), Dominion Energy (D), Walt Disney (DIS), Consolidated Edison (ED), Gilead Sciences (GILD) and Altria Group (MO).

Who are Atrion's key executives?

Atrion's management team includes the following people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 81)
  • Mr. David A. Battat, Pres & CEO (Age 49)
  • Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60)

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Who are Atrion's major shareholders?

Atrion's stock is owned by a number of retail and institutional investors. Top institutional investors include Boston Trust Walden Corp (1.38%), ProShare Advisors LLC (0.58%), Bessemer Group Inc. (0.24%), Raymond James Financial Services Advisors Inc. (0.22%), Swiss National Bank (0.18%) and First Trust Advisors LP (0.16%). Company insiders that own Atrion stock include Emile A Battat, Jeffery Strickland, John P Stupp Jr and Ronald Nicholas Spaulding.
View institutional ownership trends for Atrion

Which institutional investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including ProShare Advisors LLC, Bessemer Group Inc., Principal Financial Group Inc., New York State Common Retirement Fund, UBS Group AG, Capital Analysts LLC, US Bancorp DE, and Russell Investments Group Ltd..
View insider buying and selling activity for Atrion

Which institutional investors are buying Atrion stock?

ATRI stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, First Trust Advisors LP, MAI Capital Management, Raymond James & Associates, M&T Bank Corp, Swiss National Bank, Virtu Financial LLC, and Raymond James Financial Services Advisors Inc..
View insider buying and selling activity for Atrion

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $645.91.

How big of a company is Atrion?

Atrion has a market capitalization of $1.19 billion and generates $155.07 million in revenue each year. Atrion employs 570 workers across the globe.

What is Atrion's official website?

The official website for Atrion is www.atrioncorp.com.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.